CLINICAL_TRIALS
ClinicalTrials.gov record update
Evaluation of the Effect of the Combination of the Natural Products Glizigen® and Ocoxin®-Viusid® in the Treatment of High-grade Cervical Intraepithelial Lesions. Phase II
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT03549273
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-28T10:39:58.924094+00:00
- Published At
- 2024-02-07T00:00:00+00:00
- Record Updated At
- 2024-02-07
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Carcinoma", "Neoplasia; Intraepithelial, Cervix", "Glandular Neoplasms", "Epithelial Neoplasm", "Neoplasms"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2024-02-07"- protocolSection.identificationModule.nctId
"NCT03549273"- protocolSection.identificationModule.officialTitle
"Evaluation of the Effect of the Combination of the Natural Products Glizigen\u00ae and Ocoxin\u00ae-Viusid\u00ae in the Treatment of High-grade Cervical Intraepithelial Lesions. Phase II"- protocolSection.statusModule.overallStatus
"UNKNOWN"- protocolSection.designModule.phases
["PHASE2"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
""
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.